After 25 years with an extensive track record of success in the Medical Device space, Bucky Polk joined SBI in July 2020. He is a well-rounded executive with a vast collection of skills and experiences. Colleagues and customers have said that his authenticity, candor, and ability to connect with people are what set him apart. In his most recent role for Philips, he was responsible for the customer engagement of the most influential global Interventional Cardiologists, Vascular Surgeons, and Interventional Radiologists.
All-in-one Sensing System Poised to Unlock Bioprocessing “Black Box” PITTSBURGH, PA / ACCESSWIRE / February 16, 2021 / Scientific Bioprocessing, Inc. (SBI), a subsidiary of publicly-owned Scientific Industries, Inc. (OTCQB:SCND), announced today the launch of its Intelligent, Dynamic (ID) Fiber Optic Kit. The ID·Fiber Optic Kit is an all-in-one pH and dissolved oxygen sensing solution…
Ian is an industrial microbiologist and fermentation scientist specializing in process optimization and upstream modification of cell culture parameters for increased yield, viability, and productivity. Experienced with a variety of fermentation technologies, including hollow-fiber bioreactor systems, industrial stirred-tanks, and shake-flasks, Ian is excited to lend his background in cell culture to the SBI team.
UMBC-Scientific Bioprocessing, Inc. Collaboration Sparks Idea to Create More Hands-On Biotech Experience for Students
At the University of Maryland, Baltimore County (UMBC), Dr. Annica Wayman, Associate Dean for Shady Grove Affairs in the College of Natural and Mathematical Sciences, is seeking industry partners to support the launch of a new undergraduate degree program for UMBC students that would provide real-world, hands-on biotech experience.
Scientific Bioprocessing Inc. (SBI) is on a mission to help scientists and engineers de-risk drug development through leading-edge technology that improves the efficiency, effectiveness, and reproducibility of cell culture and bioprocessing
Experts Weigh in on the Role of Lab Automation and Sensor Technology in Advancing the Cell Therapy and Regenerative Medicine Fields
While there is tremendous excitement and ample investment around cell and gene therapy and regenerative medicine, several challenges, including scale-up, high manufacturing costs, and regulatory hurdles, continue to be impediments to the industry achieving its potential.
This webinar will host several industry leaders to discuss the latest in Lab automation solutions for small scale biotech laboratories all the way to commercial manufacturing operations.
Reinhard is the Chairman of Scientific Bioprocessing Inc. and serves on the Board of our parent company, Scientific Industries.
Sensor Technology Developed at UMBC Set to Illuminate Bioprocessing “Black Box” For years, bioprocessing engineers have struggled to monitor their experiments with large and expensive dissolved oxygen and pH electrodes [….]